Congenital hypopituitarism as a cause of undetectable estriol levels in the maternal triple-marker screen

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4144-4148

  Marshall, Ian ^a   Ugrasbul, F ^a   Manginello, F ^b   Wajnrajch, M P ^a   Shackleton, C H L ^c   New, M I ^a   Vogiatzi, M V ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b VALLEY HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; BIOCHEMICAL MARKER; ESTRIOL; STEROID 17ALPHA MONOOXYGENASE; STERYL SULFATASE;

ADENOHYPOPHYSIS; ADRENAL INSUFFICIENCY; ADULT; AMNIOCENTESIS; ARTICLE; ECHOGRAPHY; ENZYME DEFICIENCY; EVALUATION; FEMALE; FETUS DISEASE; GENETIC DISORDER; HORMONE DETERMINATION; HUMAN; HYPOPITUITARISM; KARYOTYPE 46,XX; MEASUREMENT; MOTHER; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; SCREENING; STEROID URINE LEVEL; STEROIDOGENESIS; UNITED STATES;

ADRENAL GLAND DISEASES; ADRENOCORTICOTROPIC HORMONE; ADULT; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; ESTRIOL; FEMALE; FETUS; HUMANS; HYPOPITUITARISM; INFANT, NEWBORN; NEONATAL SCREENING; PHOSPHOPROTEINS; PREGNANCY; STEROID 17-ALPHA-HYDROXYLASE; STEROIDS;

EID: 0141676040     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030495     Document Type: Article

References (31)

1. Schleifer R, Bradley L, Richards D, Ponting N 1995 Pregnancy outcome for women with very low levels of maternal serum unconjugated estriol on second-trimester screening. Am J Obstet Gynecol 173:1152-1156
2. Graves J, Miller K, Sellers A 2002 Maternal serum triple analyte screening in pregnancy. Am Fam Physician 65:915-920
3. Speiser PW, New MI 1994 Prenatal diagnosis and treatment of congenital adrenal hyperplasia. J Pediatr Endocrinol 7:183-191
4. Zachmann M, Girard J, Duc G, Illig R, Prader A 1979 Low urinary estriol during pregnancy caused by isolated fetal ACTH-deficiency. Acta Paediatr Scand Suppl 277:26-31
5. Malpuech G, Vanlieferinghen P, Dechelotte P, Gaulme J, Labbe A, Guiot F 1988 Isolated familial adrenocorticotropin deficiency: prenatal diagnosis by maternal plasma estriol assay. Am J Med Genet 29:125-130
6. Buster J, Carson S 2002 Endocrinology and diagnosis of pregnancy. In: Gabbe S, Niebyl J, Simpson J, eds. Obstetrics - normal and problem pregnancies. Philadelphia: Churchill Livingstone; 3-36
7. Pasqualini J, Kincl F 1985 Biosynthesis and metabolism of different hormones in the fetal and placental compartments. In: Pasqualini J, Kind F, eds. Hormones and the fetus. London: Pergamon Press; 73-172
8. Osathanondh R, Tulchinsky D, Kamali H, Fencl M, Taeusch H 1977 Dexamethasone levels in treated pregnant women and newborn infants. J Pediatr 90:617-620
9. Evans M, Chrousos G, Mann D, Larsen J, Green I, McCluskey J, Loriaux D, Fletcher J, Koons G, Overpeck J, Scholman JD 1985 Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia. JAMA 253:1015-1020
10. Bartels I, Caesar J, Sancken U 1994 Prenatal detection of X-linked ichthyosis bv maternal serum screening for Down syndrome. Prenat Diagn 14:227-229
11. Glass I, Lam R, Chang T, Roitman E, Shapiro L, Shackleton C 1998 Steroid sulphatase deficiency is the major cause of extremely low oestriol production at mid-pregnancy: a urinary steroid assay for the discrimination of steroid sulphatase deficiency from other causes. Prenat Diagn 18:789-800
12. Shozu M, Akasofu K, Harada T, Kubota Y 1991 A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab 72:560-566
13. Ludwig M, Beck A, Wickert L, Bolkenius U, Tittel B, Hinkel K, Bidlingmaier F 1998 Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene. J Pediatr Endocrinol Metab 11:657-664
14. Opitz J 1999 RSH (so-called Smith-Lemli-Opitz) syndrome. Curr Opin Pediatr 11:353-362
15. Opitz J, Gilbert-Barness E, Ackerman J, Lowichik A 2002 Cholesterol and development: the RSH ("Smith-Lemli-Opitz") syndrome and related conditions. Pediatr Pathol Mol Med 21:153-181
16. Bradley L, Palomaki G, Knight G, Haddow J, Opitz J, Irons M, Kelley R, Tint G 1999 Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses. Am J Med Genet 82:355-358
17. Shackleton C, Roitman E, Kratz L, Kelley R 1999 Equine type estrogens produced by a pregnant woman carrying a Smith-Lemli-Opitz syndrome fetus. J Clin Endocrinol Metab 84:1157-1159
18. Shackleton C, Roitman E, Kratz L, Kelley R 2001 Dehydro-oestriol and dehydropregnanetriol are candidate analytes for prenatal diagnosis of Smith-Lemli-Opitz syndrome. Prenat Diagn 21:207-212
19. Tajima T, Fujieda K, Kouda N, Nakae J, Miller W 2001 Heterozygous mutation in the cholesterol side chain cleavage enzyme (p450scc) gene in a patient with 46,XY sex reversal and adrenal insufficiency. J Clin Endocrinol Metab 86:3820-3825
20. Auchus R 2001 The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin North Am 30:101-119, vii
21. Guo W, Burris T, McCabe E 1995 Expression of DAX-1, the gene responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, in the hypothalamic-pituitary-adrenal/gonadal axis. Biochem Mol Med 56:8-13
22. Kelch R, Virdis R, Rappaport R, Greig F, Levine L, New M 1984 Adrenal diseases in childhood: congenital adrenal hypoplasia. In: New M, Levine L, eds. Pediatric and adolescent endocrinology. Basel: S Karger AG; 156-161
23. Reutens A, Achermann J, Ito M, Gu W, Habiby R, Donohoue P, Pang S, Hindmarsh P, Jameson J 1999 Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita. J Clin Endocrinol Metab 84:504-511
24. Fisher D 1987 Effectiveness of newborn screening programs for congenital hypothyroidism: prevalence of missed cases. Pediatr Clin North Am 34:881-890
25. Geffner M 2002 Hypopituitarism in childhood. Cancer Control 9:212-222
26. Wu W, Cogan J, Pfaffle R, Dasen J, Frisch H, O'Connell S, Flynn S, Brown M, Mullis P, Parks J, Phillips J, Rosenfeld M 1998 Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 18:147-149
27. Dattani M, Martinez-Barbera J, Thomas P, Brickman J, Gupta R, Martensson I, Toresson H, Fox M, Wales J, Hindmarsh P, Krauss S, Beddington R, Robinson I 1998 Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19:125-133
28. Netchine I, Sobrier M, Krude H, Schnabel D, Maghnie M, Marcos E, Duriez B, Cacheux V, Moers A, Goossens M, Gruters A, Amselem S 2000 Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 25:182-186
29. Machinis K, Pantel J, Netchine I, Leger J, Camand O, Sobrier M, Dastot-Le MF, Duquesnoy P, Abitbol M, Czernichow P, Amselem S 2001 Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 69:961-968
30. Shackleton C 1986 Profiling steroid hormones and urinary steroids. J Chromatogr 379:91-156
31. Chitkara U, Bowers C 1991 Laboratory assessment and values important in pregnancy. In: Cherry S, Merkatz I, eds. Complications of pregnancy: medical, surgical gynecologic, psychosocial and perinatal. Baltimore: Lippincott Williams and Wilkins; 1226-1264